Ferrero, James L.,Williams, Leslie Lugene,Sevigny, Jeffrey Joseph
申请号：
AU2015356773
公开号：
AU2015356773A1
申请日:
2015.12.02
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
A method for treatment of a human patient for Alzheimer's disease (AD) comprises sequentially administering multiple doses of a recombinant, fully human, anti-amyloid beta monoclonal antibody to the patient. In preferred embodiments, the antibody is administered in increasing amounts over a period of time. In preferred embodiments, the susceptibility of the patient to amyloid related imaging abnormalities (ARIA) is thereby reduced.
